Vera Therapeutics, Inc. (VERA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Vera Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -10.86x | -15.38x | -6.84x | -5.77x | -11.01x | -0.80x |
| P/B Ratio | 5.38x | 4.05x | 6.46x | 6.69x | 5.16x | -0.48x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 13.64x | 25.67x | 7.71x | 4.91x | 10.73x | 22.55x |
| Quick Ratio | 13.64x | 25.67x | 7.71x | 4.91x | 10.73x | 22.55x |
| Leverage | ||||||
| Debt/Equity | 0.13x | 0.09x | 0.53x | 0.41x | 0.07x | -0.00x |
YoY = year-over-year change. Source: FMP..